eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War) Receivables

As of the most recent data (June 2026), LWACU shows a receivables of $25K. That compares with $130K in the prior-year period — down 80.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LWACU's receivables is now $25K (was $130K) — a 80.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War) is outperforming or lagging.

Tracking LWACU's receivables over time shows whether eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $25K That compares with $130K in the prior-year period — down 80.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $25K) with ownership activity and broader fundamentals.

eFFECTOR Therapeutics- Units (1 Ord Share Class A & 1/3 War)'s receivables is $25K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.